Methodological Challenges in Constructing Effective Treatment Sequences for Chronic Psychiatric Disorders
- 8 November 2006
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 32 (2) , 257-262
- https://doi.org/10.1038/sj.npp.1301241
Abstract
Psychiatric disorders are often chronic conditions that require sequential decision making to achieve the best clinical outcomes. Sequential decisions are necessary to accommodate treatment response heterogeneity, a variable course of illness, and the often heavy burden associated with intensive or longer-term treatment. Yet, only a few studies in this field have been designed to address sequential decisions. Most of the experimental designs and data analytic methods that are best suited for improving sequential clinical decision making are often found in nonmedical fields such as engineering, computer science, and statistics. Promising designs and methods are surveyed with a focus on those areas most immediately useful for informing clinical decision making.Keywords
This publication has 35 references indexed in Scilit:
- Optimal Dynamic Treatment RegimesJournal of the Royal Statistical Society Series B: Statistical Methodology, 2003
- Towards robotic assistants in nursing homes: Challenges and resultsRobotics and Autonomous Systems, 2003
- A survey of industrial model predictive control technologyPublished by Elsevier ,2002
- A 'Model-on-Demand' identification methodology for non-linear process systemsInternational Journal of Control, 2001
- Multiple Recurrences of Major Depressive DisorderAmerican Journal of Psychiatry, 2000
- Medication Treatment for the Severely and Persistently Mentally IllThe Journal of Clinical Psychiatry, 1999
- The Texas Medication Algorithm ProjectThe Journal of Clinical Psychiatry, 1999
- Implementing Guidelines and Systems of CareJournal of Psychiatric Practice, 1999
- Reinforcement Learning: An IntroductionIEEE Transactions on Neural Networks, 1998
- A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-? maintenance therapy or observation, in small cell lung carcinoma patients with complete responsesCancer, 1997